How to trade Stock Options Picks Alerts, Bitcoin Stock Options Picks Alerts, Marijuana Stock Options Picks Alerts Weekly & Earnings Stock Options Picks

How to trade Marijuana Stock Options Picks , Weekly & Earnings Marijuana Stock Options Alerts 1 Month
How to trade Marijuana Stock Options Picks , Weekly & Earnings Marijuana Stock Options Alerts 1 Month
How to trade Marijuana Stock Options Picks , Weekly & Earnings Marijuana Stock Options Alerts 1 Month

How to trade Marijuana Stock Options Picks , Weekly & Earnings Marijuana Stock Options Alerts 1 Month

Regular price
Sale price
Shipping calculated at checkout.

How to trade Marijuana Stock Options Picks

Weekly & Earnings Marijuana Stock Options Alerts 1 Year. 

Subscribe Now has found a strategy that is very effective for option trading.

Top Marijuana Stocks on the NASDAQ

We provide option strategy analysis and research market data, managed by group of professional Stock Market Traders..

Increase your income trade marijuana stocks options picks


The NASDAQ was the first electronic exchange and has long been synonymous with technology and biotechnology.

The cannabis companies on the NASDAQ reflect this, with the majority of them operating in the biotech area of the industry.

Here are the NASDAQ-listed marijuana stocks, in alphabetical order,  with a breakdown of their total returns.


Past Performance


We started our service in 2012

Make Money Whether Market Moves:

Consistent, Low-Risk Income Strategy


High return with Calls and Puts UP 100 % to 1000% in One week




Down (Even Crashes)



Tilray Inc. (NASDAQ: TLRY)

Tilray Inc. was the first marijuana-related company to IPO in the U.S. The Nanaimo, Vancouver Island-based company focuses on medical cannabis products.


Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is a biotech company involved in the manufacturing of medical marijuana drugs. Research and development around Arena's APD371 is the primary focus of its cannabis biotech initiatives.


Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities for the indications of pain and pruritus (itching). Although all of their clinical-stage products target opioid receptors, Cara is currently conducting preclinical research on cannabinoids for the treatment of neuropathic pain.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is a cannabis biotech company. Its research, development, and manufacturing are based around cannabis drugs that seek to treat chronic, inflammatory, fibrotic and other diseases.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is a Canadian cannabis company. It owns and seeks cannabis related subsidiaries and licensed producers. In December of 2018, Marlboro maker Altria announced plans to invest $1.8 billion in Cronos. The investment has provided Cronos not only with additional cash to finance its continued expansion, but also with a well-established partner experienced in the process of marketing consumer brands.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is developing a portfolio of cannabinoid medicines, including Sativex for the treatment of spasticity related to multiple sclerosis and cancer pain, and Epidiolex for the treatment of childhood epilepsy. Sativex is commercialized in more than a dozen countries outside the U.S. and has received regulatory approval in several more countries. Epidiolex received FDA approval as a treatment for Dravet Syndrome and Lennox-Gastaut Syndrome, two forms of severe, early onset epilepsy without good existing treatment options. Other indications show that GW Pharmaceuticals is developing cannabinoid products for autism spectrum disorders, schizophrenia and glioma.

Insys Therapeutics Inc. (NASDAQ:INSY)

Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems. Though the company is more widely known for its Subsys fentanyl spray, Insys has received FDA approval for a dronabinol (synthetic THC) oral solution for the treatment of nausea caused by chemotherapy and anorexia in patients with AIDS. Insys is also developing cannabinoid-based treatments for epileptic disorders, Prader-Willi Syndrome (a genetic disorder) and amphetamine addiction among other indications.


Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is a clinical-stage biopharmaceutical company that is developing drugs based on its proprietary Accordion Pill technology. Intec's product pipeline includes cannabinoid-based drugs being developed for the indications of low back pain and fibromyalgia.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation operates in the enforcement sector. Its business operations support drug testing through hair samples.


Village Farms International (NASDAQ: VFF)

Village Farms International is the most recent cannabis stock to begin trading on the NASDAQ. VFF shares became available for trade on February 21, 2019. The company has a decades-long history in greenhouse produce growing and has only recently shifted some of its focus toward cannabis production.

Control Your Risk, Trade with Certainty

Short-term trading offers the best of both worlds. You can make short, fast, exciting trades combined with knowing your maximum profit or loss BEFORE you trade.

Stock Options Picks  trading weekly options.

You’ll not only learn how we trade weekly options,

You will also learn a way to increase  probabilities to your advantage.